Ronan Fougeray

Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens

Joaquim Bellmunt, Toni K. Choueiri, Ronan Fougeray et al. · Journal of Clinical Oncology · 2010 · 454 citations

Medicine, Oncology, Chemotherapy +11

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

Joaquim Bellmunt, Ronan Fougeray, Jacob Rosenberg et al. · Annals of Oncology · 2013 · 177 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

Guru Sonpavde, Gregory R. Pond, Ronan Fougeray et al. · European Urology · 2012 · 118 citations

Medicine, Oncology, Chemotherapy +3

HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced <i>EGFR</i> -mutated NSCLC after a third-generation EGFR TKI

Tony Mok, Pasi A. Jänne, Makoto Nishio et al. · Future Oncology · 2023 · 57 citations · Full text

Medicine, Oncology, Pharmacology +13

Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study.

Josep Tabernero, Gerald W. Prager, Marwan Fakih et al. · Journal of Clinical Oncology · 2023 · 48 citations · Full text

Medicine, Oncology, Pharmacology +12